On September 30, 2026, FMR LLC sold 83,000 shares of Consun Pharmaceutical Group Ltd. (01681) on the SEHK open market at an average of HKD 14.5448 per share, involving about HKD 1.21 million. This is an on-exchange active trade, a direct dealing in the secondary market.
Prior to the disposal, FMR LLC's long position in CONSUN PHARMA was 75.82 million shares, representing 9.01%; following the disposal, the holding changed to 75.73 million shares, with the long position ratio falling to 8.99%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.